Skip to search formSkip to main contentSkip to account menu

PCA 4230

Known as: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,4,6-trimethyl-, ethyl 2-(3-oxo-1,2-benzisothiazol-2(3H)-yl)ethyl ester, S,S-dioxide, PCA-4230 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
In the present study we examined the effects of PCA‐4230, a novel antithrombotic agent, on the growth of cultured A10 vascular… 
1997
1997
1 In the present study we examined the e€ects of PCA-4230, a novel antithrombotic agent, on the growth of cultured A10 vascular… 
1993
1993
In the present study we described the effects of a new 1,4-dihydropyridine derivative with antithrombotic activity on… 
1992
1992
The effects of a new antithrombotic compound, PCA-4230, versus ticlopidine were investigated using an experimental thrombosis and… 
1987
1987
PCA-4230 is a new anti-thrombotic compound which inhibits pla. telet aggregation In vltn.0 and ex. vivo in several species…